Swertiamarin treatment significantly (P < 0.05) reversed the down regulated expression of INSR-β, PI(3)K, p-Akt and PKC-ζ in PCOS-IR hLGCs. This evidence concerns the gene AKT1 and polycystic ovary syndrome.